Literature DB >> 24363605

Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins.

Xueli Zhang1, Chongzhao Ran2.   

Abstract

Misfolding of a protein is a destructive process for variety of diseases that include neurodegenerative diseases such as Alzheimer's disease, Parkinson disease, Huntington disease, mad cow disease, amyotrophic lateral sclerosis (ALS), and frontal temporal dementia (FTD), and other non-CNS diseases such as diabetes, cystic fibrosis, and lysosomal storage diseases. Formation of various misfunctional large assembles of the misfolded protein is the primary consequence. To detect the formation of the aggregated species is very important for not only basic mechanism research but also very crucial for diagnosis of the diseases. In this review, we updated references related to the new development of the dual functional fluorescent small molecule probes for detecting the aggregated proteins in vitro and in vivo.

Entities:  

Keywords:  Alzheimer’s disease; Dual functional probes; fluorescent imaging; fluorescent probe; in vivo imaging; misfolding proteins; near infrared imaging; neurodegenerative disease; neurodegenerative diseases

Year:  2013        PMID: 24363605      PMCID: PMC3867281          DOI: 10.2174/1385272811317060004

Source DB:  PubMed          Journal:  Curr Org Chem        ISSN: 1385-2728            Impact factor:   2.180


  117 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Regulation of insulin gene transcription.

Authors:  D Melloul; S Marshak; E Cerasi
Journal:  Diabetologia       Date:  2002-03       Impact factor: 10.122

Review 3.  Regulation of the insulin gene transcription by glucose.

Authors:  Noboru Furukawa; Tetsuya Shirotani; Kazuhiko Nakamaru; Kazuya Matsumoto; Motoaki Shichiri; Eiichi Araki
Journal:  Endocr J       Date:  2002-04       Impact factor: 2.349

Review 4.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Authors:  Vasilis Ntziachristos; Christoph Bremer; Ralph Weissleder
Journal:  Eur Radiol       Date:  2002-07-19       Impact factor: 5.315

Review 5.  Translating cell biology into therapeutic advances in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 6.  Parkinson disease: etiology, pathogenesis and future of gene therapy.

Authors:  B S Shastry
Journal:  Neurosci Res       Date:  2001-09       Impact factor: 3.304

7.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.

Authors:  Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Bin Zhang; Daniel Skovronsky; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

10.  Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

Authors:  Per Hammarström; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Science       Date:  2003-01-31       Impact factor: 47.728

View more
  5 in total

Review 1.  Advances in development of fluorescent probes for detecting amyloid-β aggregates.

Authors:  Ming-Ming Xu; Wen-Ming Ren; Xi-Can Tang; You-Hong Hu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-03-21       Impact factor: 6.150

2.  Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains.

Authors:  Etheresia Pretorius; Martin J Page; Lisa Hendricks; Nondumiso B Nkosi; Sven R Benson; Douglas B Kell
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

Review 3.  To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Semin Thromb Hemost       Date:  2017-08-04       Impact factor: 4.180

Review 4.  Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease.

Authors:  Hongjuan Tong; Kaiyan Lou; Wei Wang
Journal:  Acta Pharm Sin B       Date:  2015-01-02       Impact factor: 11.413

5.  Design and synthesis of a fluorescent probe based on naphthalene anhydride and its detection of copper ions.

Authors:  Guangjie He; Chenxi Liu; Xiaobo Liu; Qingzhi Wang; Aiying Fan; Songjun Wang; Xinlai Qian
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.